ACT Methylphenidate ER (2020-02-07)
- Starting date:
- February 7, 2020
- Type of communication:
- Drug Recall
- Subcategory:
- Drugs
- Hazard classification:
- Type II
- Source of recall:
- Health Canada
- Issue:
- Product Safety
- Audience:
- General Public, Healthcare Professionals, Hospitals
- Identification number:
- RA-72305
Last updated: 2020-02-10
Summary
-
Product:
ACT Methylphenidate ER 18 mg Tablet
Reason
Affected lot(s) may be missing the desiccant.
Depth of distribution
Wholesalers, Healthcare Establishments, Retailers
Affected products
ACT Methylphenidate ER 18 mg Tablet
DIN, NPN, DIN-HIM
DIN 02441934
Dosage form
Tablet (Extended-Release)
Strength
Methylphenidate hydrochloride 18 mg
Lot or serial number
1293319A
Companies
- Recalling Firm
-
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA
- Marketing Authorization Holder
-
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA